The Walter Reed staging classification for HTLV-III/LAV infection.
about
Management of cerebral infection.Increasing rates of obesity among HIV-infected persons during the HIV epidemicThe effect of a single course of alpha-2B-interferon in patients with HIV-related and chronic idiopathic immune thrombocytopenia.Immunocytochemical demonstration of human immunodeficiency virus infected cells in the cerebrospinal fluid.Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genomeRisk behavior-based model of the cubic growth of acquired immunodeficiency syndrome in the United States.Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.Candida and oral candidosis: a review.Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseHuman immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical stagingValidity of a self-reported history of a positive tuberculin skin test. A prospective study of drug usersThe epidemiology of the oral lesions of HIV infection in the developed world.Progression of HIV-infection: markers or determinants.Postmortem localization of HIV-1 RNA by in situ hybridization in lymphoid tissues of intravenous drug addicts who died unexpectedlySequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1β: Possible Implications for Mechanisms of T Cell Depletion in HIV DiseaseGenerality of the final size formula for an epidemic of a newly invading infectious disease.Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolatesTumour necrosis factor-alpha mediates blood-brain barrier damage in HIV-1 infection of the central nervous system.Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophagesSynthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzeesSeropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey.Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU)Isolation of Mycoplasma species from bronchoalveolar lavages of patients positive and negative for human immunodeficiency virus.Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical statusImpairment of colour contrast sensitivity and neuroretinal dysfunction in patients with symptomatic HIV infection or AIDS.Cutaneous malignancies among HIV-infected persons.An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.Formulating AIDS policy.Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro.Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.Surgery for anal lesions in HIV-infected patients.Loss of periodontal attachment in HIV-seropositive military personnel.Neuropsychological functioning of HIV-infected males.Cardiac dysfunction in patients seropositive for the human immunodeficiency virus.
P2860
Q27469303-C6ED6069-914C-44A0-9345-A65CC01193B8Q28473706-5094D163-78B8-4B62-AEBE-9A40D0FBE7ADQ33493677-7889B6EB-F81A-4812-8F7A-FA31136ACDE3Q33631484-828D72B5-7877-40B0-B3E3-CA558B4D75BFQ33649232-F94099B7-13E3-4B94-A319-CA58E3CA45CBQ33864846-641DE764-78D6-4F5E-A3B7-15312AD57C0DQ33892180-C5B1ACCC-8E76-45A1-AD17-3AFF63881564Q34318789-C2A54EE3-8AC1-42A2-9045-121DB9979042Q34334948-0B9E8230-47C3-4223-A0BF-7B23A48D7BF5Q34341001-62BE1CC1-BD79-432C-B67B-62064E8C3CBBQ34531090-61D98E6C-D465-44BB-95D5-6DE231C4CDDDQ34581195-2563907A-D10A-4682-87EC-ADDA647CAFBCQ34733731-1B621FBB-933E-46B3-A5EB-156AB9D0F3CFQ34775248-D7963971-4ADB-4F82-A8DB-976FE88DB55CQ35280089-0D0BC2C8-B185-4451-AA95-AC21F8FAD928Q35833038-923CDFC5-74AC-4FEB-828D-FAD8DFBF7C29Q36046570-2B7AC708-955E-45CA-B66F-FB813F224A66Q36177047-C11F16E5-529D-4263-BE7C-75BD06AF466AQ36516515-32B62864-BE23-4657-A6CA-48705F65335DQ36518997-39AAD37D-A9C9-46FC-8927-78AF7E59BD95Q36626957-8DAB2A66-80AC-4819-8344-3E6BA2E5E0DDQ36797335-CB17A712-04CD-470B-8415-63819F3D798BQ36800188-8B338FA2-7A35-4C0B-B679-2E482055A4F7Q36895424-0F4B9046-C655-439B-A994-BDFC8E7D1AE7Q36895610-BF909DF4-1108-4277-B593-E328D860DA62Q36989554-19246F53-A95D-40D1-8D6E-4061723C4112Q37086770-CD6EA3B7-A6E4-4ACD-986E-4FBE413C5C86Q37172434-DEB15F80-77E4-4B0A-AA24-1CA3F07AF04BQ37221162-992ED05B-4B97-4F99-8EC1-1D5015D1D4B5Q37303888-5822AA02-1CD1-4526-871D-0C08009EDAE4Q37387284-D7E2D770-AE6D-4F17-9B9C-6A6AB01ADB63Q37723559-6C7B6BD4-F107-4D99-8A0C-39C6F89D78D7Q39572065-99EAB3F3-3543-4B89-ACDB-0E1031576040Q40049075-7F8C9367-B8F0-4DC0-ABB2-727E3FA56BA1Q40109856-7015A74C-38E6-4F75-8602-810D0AC31011Q40189078-83232B90-6AB1-4518-A4FE-0C515989F0EDQ40921516-3A26B916-424A-4617-B873-003E2E66898AQ40984673-6F00162F-55D6-4717-8E3F-F7205BE8D34EQ41158518-6998683B-4CAD-49FB-B874-D5BA01EE8B94Q41189251-2AE4571D-0580-4972-B423-C6D81A2F887E
P2860
The Walter Reed staging classification for HTLV-III/LAV infection.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
The Walter Reed staging classification for HTLV-III/LAV infection.
@en
The Walter Reed staging classification for HTLV-III/LAV infection.
@nl
type
label
The Walter Reed staging classification for HTLV-III/LAV infection.
@en
The Walter Reed staging classification for HTLV-III/LAV infection.
@nl
prefLabel
The Walter Reed staging classification for HTLV-III/LAV infection.
@en
The Walter Reed staging classification for HTLV-III/LAV infection.
@nl
P2093
P1476
The Walter Reed staging classification for HTLV-III/LAV infection.
@en
P2093
D C Wright
E C Tramont
R R Redfield
P304
P356
10.1056/NEJM198601093140232
P407
P577
1986-01-01T00:00:00Z